268 related articles for article (PubMed ID: 23836420)
1. O-GlcNAc in cancer biology.
Ma Z; Vosseller K
Amino Acids; 2013 Oct; 45(4):719-33. PubMed ID: 23836420
[TBL] [Abstract][Full Text] [Related]
2. Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.
Ma Z; Vosseller K
J Biol Chem; 2014 Dec; 289(50):34457-65. PubMed ID: 25336642
[TBL] [Abstract][Full Text] [Related]
3. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
Ma Z; Vocadlo DJ; Vosseller K
J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
[TBL] [Abstract][Full Text] [Related]
4. Essential role of O-GlcNAcylation in stabilization of oncogenic factors.
Makwana V; Ryan P; Patel B; Dukie SA; Rudrawar S
Biochim Biophys Acta Gen Subj; 2019 Aug; 1863(8):1302-1317. PubMed ID: 31034911
[TBL] [Abstract][Full Text] [Related]
5. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
6. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
Goldberg H; Whiteside C; Fantus IG
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAc signaling: a metabolic link between diabetes and cancer?
Slawson C; Copeland RJ; Hart GW
Trends Biochem Sci; 2010 Oct; 35(10):547-55. PubMed ID: 20466550
[TBL] [Abstract][Full Text] [Related]
8. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
Hanover JA; Chen W; Bond MR
J Bioenerg Biomembr; 2018 Jun; 50(3):155-173. PubMed ID: 29594839
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
Park SY; Ryu J; Lee W
Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAc modification, insulin signaling and diabetic complications.
Issad T; Masson E; Pagesy P
Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
[TBL] [Abstract][Full Text] [Related]
11. [O-GlcNAc glycosylation and regulation of cell signaling].
Issad T
Med Sci (Paris); 2010; 26(8-9):753-9. PubMed ID: 20819714
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy.
Lu Q; Zhang X; Liang T; Bai X
Mol Med; 2022 Sep; 28(1):115. PubMed ID: 36104770
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.
Ferrer CM; Sodi VL; Reginato MJ
J Mol Biol; 2016 Aug; 428(16):3282-3294. PubMed ID: 27343361
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cancer metabolism by O-GlcNAcylation.
Li Z; Yi W
Glycoconj J; 2014 Apr; 31(3):185-91. PubMed ID: 24323367
[TBL] [Abstract][Full Text] [Related]
15. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
Phillips RM; Lam C; Wang H; Tran PT
Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
[TBL] [Abstract][Full Text] [Related]
16. Role of O-GlcNAcylation in nutritional sensing, insulin resistance and in mediating the benefits of exercise.
Myslicki JP; Belke DD; Shearer J
Appl Physiol Nutr Metab; 2014 Nov; 39(11):1205-13. PubMed ID: 25203141
[TBL] [Abstract][Full Text] [Related]
17. Roles of O-GlcNAc in chronic diseases of aging.
Banerjee PS; Lagerlöf O; Hart GW
Mol Aspects Med; 2016 Oct; 51():1-15. PubMed ID: 27259471
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer.
Champattanachai V; Netsirisawan P; Chaiyawat P; Phueaouan T; Charoenwattanasatien R; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J
Proteomics; 2013 Jul; 13(14):2088-99. PubMed ID: 23576270
[TBL] [Abstract][Full Text] [Related]
19. The role of O-linked GlcNAc modification on the glucose response of ChREBP.
Sakiyama H; Fujiwara N; Noguchi T; Eguchi H; Yoshihara D; Uyeda K; Suzuki K
Biochem Biophys Res Commun; 2010 Nov; 402(4):784-9. PubMed ID: 21036147
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAc protein modification in cancer cells increases in response to glucose deprivation through glycogen degradation.
Kang JG; Park SY; Ji S; Jang I; Park S; Kim HS; Kim SM; Yook JI; Park YI; Roth J; Cho JW
J Biol Chem; 2009 Dec; 284(50):34777-84. PubMed ID: 19833729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
